secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xilio Therapeutics, Inc. (XLO)
CIK:        0001840233
Form:       8-K
Filed at:   2025-04-08T23:59:59+00:00
Accession:  0001558370-25-004599
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Xilio receives Nasdaq bid-price deficiency letter for shares below $1.00
------------------------------------------------------------------------

- Notice dated April 4, 2025; stock closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Oct 1, 2025) to regain compliance.
- To cure, bid price must close at or above $1.00 for at least 10 consecutive business days.
- If not cured, Xilio may transfer to Nasdaq Capital Market for an additional 180-day period.
- No immediate effect on listing; company evaluating options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840233/000155837025004599/0001558370-25-004599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840233/000155837025004599/xlo-20250404x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-004599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer